Swiss medtech startup Medyria secures series B financing round and approval for clinical trial
12.02.2018
Medyria has achieved an important milestone and will further develop its technology.
 Medyria technology
|
 |
Venture Kick alumnus in 2012 and winner of CHF 30,000, Medyria has announced the successful closing of a CHF 3.7 million Series B financing round with investiere.ch and the approval for first-in-man clinical trials. The medtech company based in Winterthur raised a CHF 2.2 million Series A investment in 2015 and is now ready to achieve important goals with the new capital injection.
Medyria has specialized in developing technologies for cardiovascular catheter navigation and sensing which aim to reduce the risk during the surgical procedures.
Medyria has specialized in developing technologies for cardiovascular catheter navigation and sensing which aim to reduce the risk during the surgical procedures.